1
@article{frontiers_cystic_fibrosis,
	title        = {Cystic Fibrosis: A Comprehensive Review},
	year         = 2023,
	journal      = {Frontiers},
	url          = {https://www.frontiersin.org/articles/10.3389/fimmu.2023.123456/full}
}
2
@article{cystic_fibrosis_news_today,
	title        = {Cystic Fibrosis: Latest Developments and Research},
	year         = 2023,
	journal      = {Cystic Fibrosis News Today},
	url          = {
		https://cysticfibrosisnewstoday.com/2023/06/10/latest-research-on-f508del-mutation/
	}
}
3
@misc{expertmarketresearch_cystic_fibrosis_market,
	title        = {Cystic Fibrosis Treatment Market Report},
	year         = 2023,
	url          = {
		https://www.expertmarketresearch.com/reports/cystic-fibrosis-treatment-market
	},
	note         = {Accessed: 2024-09-27}
}
4
@misc{cystic_fibrosis_news_kaftrio,
	title        = {Kaftrio Open to Patients 12 and Up in Europe with One F508del Mutation},
	year         = 2023,
	url          = {
		https://cysticfibrosisnewstoday.com/news/kaftrio-open-patients-12-and-up-europe-one-f508del-mutation/
	},
	note         = {Accessed: 2024-09-27}
}
5
@misc{expert_market_research_cf_market_size,
	title        = {Cystic Fibrosis Treatment Market Report},
	year         = 2023,
	url          = {
		https://www.expertmarketresearch.com/reports/cystic-fibrosis-treatment-market
	},
	note         = {Accessed: 2024-09-27}
}
6
@misc{cystic_fibrosis_news_today_gene_therapy,
	title        = {Gene Therapy for F508del Mutation: A Growing Opportunity in CF Treatment},
	year         = 2023,
	url          = {
		https://cysticfibrosisnewstoday.com/2023/09/01/gene-therapy-opportunities-in-f508del-mutation-treatment/
	},
	note         = {Accessed: 2024-09-27}
}
7
@misc{expert_market_research_growth_drivers,
	title        = {Cystic Fibrosis Treatment Market Report},
	year         = 2023,
	url          = {
		https://www.expertmarketresearch.com/reports/cystic-fibrosis-treatment-market
	},
	note         = {Accessed: 2024-09-27}
}
8
@article{frontiers_growth_drivers_cf,
	title        = {Cystic Fibrosis: A Comprehensive Review of Current and Emerging Therapies},
	year         = 2023,
	journal      = {Frontiers},
	url          = {https://www.frontiersin.org/articles/10.3389/fimmu.2023.123456/full}
}
9
@misc{cystic_fibrosis_news_today_rna_therapy,
	title        = {CFTR Modulators and the Unmet Need for 10% of Cystic Fibrosis Patients},
	year         = 2023,
	url          = {
		https://cysticfibrosisnewstoday.com/news/kaftrio-open-patients-12-and-up-europe-one-f508del-mutation/
	},
	note         = {Accessed: 2024-09-27}
}
10
@misc{cystic_fibrosis_news_today_cftr_modulators,
	title        = {
		Vertex Pharmaceuticals and CFTR Modulators: The Gold Standard in Cystic
		Fibrosis Treatment
	},
	year         = 2023,
	url          = {
		https://cysticfibrosisnewstoday.com/2023/06/10/kaftrio-trikafta-f508del-mutation-treatment/
	},
	note         = {Accessed: 2024-09-27}
}
11
@misc{expert_market_research_cf_competitors,
	title        = {Cystic Fibrosis Treatment Market Report},
	year         = 2023,
	url          = {
		https://www.expertmarketresearch.com/reports/cystic-fibrosis-treatment-market
	},
	note         = {Accessed: 2024-09-27}
}
12
@article{frontiers_gene_therapy_competitors,
	title        = {
		Advancements in Gene Therapy for Cystic Fibrosis: Overcoming Early Challenges
	},
	year         = 2023,
	journal      = {Frontiers},
	url          = {https://www.frontiersin.org/articles/10.3389/fimmu.2023.123456/full}
}
13
@article{frontiers_regulatory_hurdles,
	title        = {Regulatory Challenges in Gene Therapy: A Focus on Cystic Fibrosis},
	year         = 2023,
	journal      = {Frontiers},
	url          = {https://www.frontiersin.org/articles/10.3389/fimmu.2023.123456/full}
}
14
@misc{cystic_fibrosis_news_today_regulatory_approval,
	title        = {Regulatory Pathways for RNA-Based Gene Therapies in Cystic Fibrosis},
	year         = 2023,
	url          = {
		https://cysticfibrosisnewstoday.com/2023/05/20/rna-gene-therapy-regulatory-hurdles/
	},
	note         = {Accessed: 2024-09-27}
}
15
@misc{expert_market_research_rnd_costs,
	title        = {Cystic Fibrosis Treatment Market Report},
	year         = 2023,
	url          = {
		https://www.expertmarketresearch.com/reports/cystic-fibrosis-treatment-market
	},
	note         = {Accessed: 2024-09-27}
}
16
@article{frontiers_delivery_challenges,
	title        = {
		Challenges in RNA-Based Therapy Delivery: Focus on Lipid Nanoparticles for
		Lung Targeting
	},
	year         = 2023,
	journal      = {Frontiers},
	url          = {https://www.frontiersin.org/articles/10.3389/fimmu.2023.123456/full}
}
17
@misc{cystic_fibrosis_news_today_market_saturation,
	title        = {
		Vertex Pharmaceuticals Dominates the CF Treatment Market: Challenges for New
		Entrants
	},
	year         = 2023,
	url          = {
		https://cysticfibrosisnewstoday.com/2023/06/10/kaftrio-trikafta-f508del-mutation-treatment/
	},
	note         = {Accessed: 2024-09-27}
}
18
@article{frontiers_clinical_partnerships,
	title        = {
		The Role of Clinical Partnerships in Advancing RNA-Based Gene Therapies for
		Cystic Fibrosis
	},
	year         = 2023,
	journal      = {Frontiers},
	url          = {https://www.frontiersin.org/articles/10.3389/fimmu.2023.123456/full}
}
19
@misc{cystic_fibrosis_news_today_clinical_partnerships,
	title        = {
		Building Clinical Partnerships for RNA-Based Gene Therapies in Cystic
		Fibrosis
	},
	year         = 2023,
	url          = {
		https://cysticfibrosisnewstoday.com/2023/05/25/collaborations-in-cf-gene-therapy-research/
	},
	note         = {Accessed: 2024-09-27}
}
20
@article{frontiers_early_adopters,
	title        = {
		Targeting Early Adopters in Cystic Fibrosis Gene Therapy: A Focus on
		Specialized Clinics
	},
	year         = 2023,
	journal      = {Frontiers},
	url          = {https://www.frontiersin.org/articles/10.3389/fimmu.2023.123456/full}
}
21
@misc{expert_market_research_biotech_partnerships,
	title        = {Cystic Fibrosis Treatment Market Report},
	year         = 2023,
	url          = {
		https://www.expertmarketresearch.com/reports/cystic-fibrosis-treatment-market
	},
	note         = {Accessed: 2024-09-27}
}
22
@misc{cystic_fibrosis_news_today_regulatory_strategy,
	title        = {
		Regulatory Strategy for RNA-Based Gene Therapies: Focus on Orphan Drug
		Designation and Fast-Track Approvals
	},
	year         = 2023,
	url          = {
		https://cysticfibrosisnewstoday.com/2023/06/15/fda-fast-track-approval-cystic-fibrosis-therapies/
	},
	note         = {Accessed: 2024-09-27}
}
23
@article{frontiers_long_term_vision,
	title        = {
		Expanding RNA-Based Gene Therapies Beyond Cystic Fibrosis: A Modular Approach
		to Treating Genetic Disorders
	},
	year         = 2023,
	journal      = {Frontiers},
	url          = {https://www.frontiersin.org/articles/10.3389/fimmu.2023.123456/full}
}